Medtronic Announces FDA Approval for Minimed™ 770G Insulin Pump System with Smartphone Connectivity for People with Type 1 Diabetes
Medtronic announced approval of its MiniMed™ 770G hybrid closed loop system this month. The new insulin pump system offers the…
Weekly Coronavirus Resources for People with T1D – 8/07/2020
We’re going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.
Weekly Coronavirus Resources for People with T1D – 7/03/2020
We’re going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.
Weekly Coronavirus Resources for People with T1D – 6/12/2020
We’re going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.
Weekly Coronavirus Resources for People with T1D – 6/05/2020
We’re going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.
CEO DAVID WALTON INTERVIEWED ON THE JUICEBOX PODCAST
David Walton, CEO of T1D Exchange, sat down this week with Scott Benner, host of the Juicebox Podcast, to talk about their respective history with type 1 diabetes. The conversation covered a wide range of topics: Scott and Dave discussed their personal relationships with T1D, experiences in the industry, and strategies for dealing with the disease. …
Continue reading “CEO DAVID WALTON INTERVIEWED ON THE JUICEBOX PODCAST”
Eli Lilly Announces Groundbreaking Affordable Insulin Program.
Lately, we are inundated with negative reports and information surrounding the Coronavirus outbreak. Fortunately, there is some good news for people with type 1 diabetes. Eli Lilly announced that beginning April 6, 2020, and for $35.00 dollars a month regardless of having a health insurance plan or not having health insurance at all, people with …
Continue reading “Eli Lilly Announces Groundbreaking Affordable Insulin Program.”
Diasome Announces Positive Results for HDV Insulin Additive to Manage Blood Sugar
Diasome Pharmaceuticals announced positive results this week from a Phase 2 study of its injectable hepatocyte directed vesicle (HDV) additive for insulin in patients with type 1 diabetes. The news could prove a major step forward for therapies that aim to improve and optimize the way insulin is used and metabolized by the body. In …
Continue reading “Diasome Announces Positive Results for HDV Insulin Additive to Manage Blood Sugar”
Pharma and Medtech CEOs at JPMorgan 2020 Weigh in on Insulin Pricing, Supply Issues, and Innovation
Executives of the Big Three pharma companies involved in diabetes research, development, and manufacturing — Eli Lilly and Co., Novo Nordisk, and Sanofi — spoke publicly this week at JPMorgan’s 2020 Healthcare conference on issues related to insulin pricing and supply.
FDA Approves Fiasp Ultra-Fast Acting Insulin for Children with Type 1 Diabetes
The U.S. Food and Drug Administration has approved Novo Nordisk’s fast-acting Fiasp insulin for use in children as well as adults, the pharmaceutical firm announced Monday.
